M. Leon et Mc. Kew, LOSS OF HETEROZYGOSITY IN CHROMOSOME 4Q12-Q13 IN HEPATOCELLULAR-CARCINOMA IN SOUTHERN AFRICAN BLACKS, Anticancer research, 16(1), 1996, pp. 349-351
Paired samples of hepatocellular carcinoma and non-tumorous hepatic ti
ssue from 12 southern African blacks were examined for loss of heteroz
ygosity at two loci (D4S409 and D4S392) in chromosome 4q12-q13 (mappin
g to the same region as the locus for the gene for alpha-fetoprotein).
Deoxyribonucleic acid was extracted from carcinoma and non-tumorous t
issues and amplified using the polymerase chain reaction. The primers
used were based on flanking regions of minisatellite DNA specific for
the loci. Products of PCR amplification were separated by denaturing p
olyacrylamide gel electrophoresis and analysed for allelic losses. At
the D4S409 locus one of seven informative samples showed loss of heter
ozygosity, whereas none of eight informative samples showed loss of he
terozygosity at the D4S392 locus. If these findings are considered tog
ether with those previously reported in hepatocellular carcinomas from
black Africans, the prevalence of loss of heterozygosity in chromosom
e 4q12-q13 in hepatocellular carcinoma in southern African blacks (33
per cent) is the same as that in tumours from Japanese patients. Loss
of heterozygosity at chromosome 4q12-q13 is infrequent during hepatoce
llular carcinogenesis in southern African blacks.